Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Harmonization of PCR-based detection of intestinal pathogens: experiences from the Dutch external quality assessment scheme on molecular diagnosis of protozoa in stool samples.

Schuurs TA, Koelewijn R, Brienen EAT, Kortbeek T, Mank TG, Mulder B, Stelma FF, van Lieshout L, van Hellemond JJ.

Clin Chem Lab Med. 2018 Feb 16. pii: /j/cclm.ahead-of-print/cclm-2017-1057/cclm-2017-1057.xml. doi: 10.1515/cclm-2017-1057. [Epub ahead of print]

PMID:
29451859
2.

Dynamics of the Immune Response in Acute Hepatitis B Infection.

Stelma F, Willemse SB, Erken R, de Niet A, Sinnige MJ, van Dort K, Zaaijer HL, van Leeuwen EMM, Kootstra NA, Reesink HW.

Open Forum Infect Dis. 2017 Dec 20;4(4):ofx231. doi: 10.1093/ofid/ofx231. eCollection 2017 Fall.

3.

Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing.

van der Ree MH, Stelma F, Willemse SB, Brown A, Swadling L, van der Valk M, Sinnige MJ, van Nuenen AC, de Vree JML, Klenerman P, Barnes E, Kootstra NA, Reesink HW.

Antiviral Res. 2017 Oct;146:139-145. doi: 10.1016/j.antiviral.2017.08.016. Epub 2017 Aug 24.

4.

Peg-interferon plus nucleotide analogue in patients with chronic hepatitis B with low viral load - Authors' reply.

Jansen L, Stelma F, Niet A, Reesink HW.

Lancet Gastroenterol Hepatol. 2017 Sep;2(9):629. doi: 10.1016/S2468-1253(17)30221-2. No abstract available.

PMID:
28786385
5.

Human intrahepatic CD69 + CD8+ T cells have a tissue resident memory T cell phenotype with reduced cytolytic capacity.

Stelma F, de Niet A, Sinnige MJ, van Dort KA, van Gisbergen KPJM, Verheij J, van Leeuwen EMM, Kootstra NA, Reesink HW.

Sci Rep. 2017 Jul 21;7(1):6172. doi: 10.1038/s41598-017-06352-3.

6.

HBsAg loss after peginterferon-nucleotide combination treatment in chronic hepatitis B patients: 5 years of follow-up.

Stelma F, van der Ree MH, Jansen L, Peters MW, Janssen HLA, Zaaijer HL, Takkenberg RB, Reesink HW.

J Viral Hepat. 2017 Dec;24(12):1107-1113. doi: 10.1111/jvh.12738. Epub 2017 Jul 29.

PMID:
28632898
7.

Peg-interferon plus nucleotide analogue treatment versus no treatment in patients with chronic hepatitis B with a low viral load: a randomised controlled, open-label trial.

de Niet A, Jansen L, Stelma F, Willemse SB, Kuiken SD, Weijer S, van Nieuwkerk CMJ, Zaaijer HL, Molenkamp R, Takkenberg RB, Koot M, Verheij J, Beuers U, Reesink HW.

Lancet Gastroenterol Hepatol. 2017 Aug;2(8):576-584. doi: 10.1016/S2468-1253(17)30083-3. Epub 2017 May 15.

PMID:
28522204
8.

Peginterferon add-on: an added benefit?

Stelma F, Reesink HW.

Lancet Gastroenterol Hepatol. 2017 Mar;2(3):147-148. doi: 10.1016/S2468-1253(16)30220-5. Epub 2017 Jan 20. No abstract available.

PMID:
28404122
9.

Immune phenotype and function of natural killer and T cells in chronic hepatitis C patients who received a single dose of anti-MicroRNA-122, RG-101.

Stelma F, van der Ree MH, Sinnige MJ, Brown A, Swadling L, de Vree JML, Willemse SB, van der Valk M, Grint P, Neben S, Klenerman P, Barnes E, Kootstra NA, Reesink HW.

Hepatology. 2017 Jul;66(1):57-68. doi: 10.1002/hep.29148. Epub 2017 Jun 7.

10.

Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial.

van der Ree MH, de Vree JM, Stelma F, Willemse S, van der Valk M, Rietdijk S, Molenkamp R, Schinkel J, van Nuenen AC, Beuers U, Hadi S, Harbers M, van der Veer E, Liu K, Grundy J, Patick AK, Pavlicek A, Blem J, Huang M, Grint P, Neben S, Gibson NW, Kootstra NA, Reesink HW.

Lancet. 2017 Feb 18;389(10070):709-717. doi: 10.1016/S0140-6736(16)31715-9. Epub 2017 Jan 11.

PMID:
28087069
11.

Soluble TLR2 and 4 concentrations in cerebrospinal fluid in HIV/SIV-related neuropathological conditions.

Mothapo KM, Ten Oever J, Koopmans P, Stelma FF, Burm S, Bajramovic J, Verbeek MM, Rikkert MGO, Netea MG, Koopman G, van der Ven AJ.

J Neurovirol. 2017 Apr;23(2):250-259. doi: 10.1007/s13365-016-0495-7. Epub 2016 Nov 23.

PMID:
27882497
12.

Novel gene function revealed by mouse mutagenesis screens for models of age-related disease.

Potter PK, Bowl MR, Jeyarajan P, Wisby L, Blease A, Goldsworthy ME, Simon MM, Greenaway S, Michel V, Barnard A, Aguilar C, Agnew T, Banks G, Blake A, Chessum L, Dorning J, Falcone S, Goosey L, Harris S, Haynes A, Heise I, Hillier R, Hough T, Hoslin A, Hutchison M, King R, Kumar S, Lad HV, Law G, MacLaren RE, Morse S, Nicol T, Parker A, Pickford K, Sethi S, Starbuck B, Stelma F, Cheeseman M, Cross SH, Foster RG, Jackson IJ, Peirson SN, Thakker RV, Vincent T, Scudamore C, Wells S, El-Amraoui A, Petit C, Acevedo-Arozena A, Nolan PM, Cox R, Mallon AM, Brown SD.

Nat Commun. 2016 Aug 18;7:12444. doi: 10.1038/ncomms12444.

13.

The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis.

Leeflang MM, Ang CW, Berkhout J, Bijlmer HA, Van Bortel W, Brandenburg AH, Van Burgel ND, Van Dam AP, Dessau RB, Fingerle V, Hovius JW, Jaulhac B, Meijer B, Van Pelt W, Schellekens JF, Spijker R, Stelma FF, Stanek G, Verduyn-Lunel F, Zeller H, Sprong H.

BMC Infect Dis. 2016 Mar 25;16:140. doi: 10.1186/s12879-016-1468-4. Review.

14.

HLA-C and KIR combined genotype as new response marker for HBeAg-positive chronic hepatitis B patients treated with interferon-based combination therapy.

Stelma F, Jansen L, Sinnige MJ, van Dort KA, Takkenberg RB, Janssen HL, Reesink HW, Kootstra NA.

J Viral Hepat. 2016 Aug;23(8):652-9. doi: 10.1111/jvh.12525. Epub 2016 Mar 4.

PMID:
26945896
15.

Bacterial Tracheitis and Septic Shock.

Tak R, Semmekrot B, Warris A, Yntema JB, Stelma F, Neeleman C.

Pediatr Infect Dis J. 2016 Feb;35(2):226-7. doi: 10.1097/INF.0000000000000981. No abstract available.

PMID:
26756267
16.

Restoration of T cell function in chronic hepatitis B patients upon treatment with interferon based combination therapy.

de Niet A, Stelma F, Jansen L, Sinnige MJ, Remmerswaal EB, Takkenberg RB, Kootstra NA, Reesink HW, van Lier RA, van Leeuwen EM.

J Hepatol. 2016 Mar;64(3):539-46. doi: 10.1016/j.jhep.2015.10.013. Epub 2015 Oct 24.

PMID:
26505119
17.

A Dutch nationwide evaluation of serological assays for detection of Borrelia antibodies in clinically well-defined patients.

Ang CW, Brandenburg AH, van Burgel ND, Bijlmer HA, Herremans T, Stelma F, Lunel FV, van Dam AP; Dutch Working Group on Diagnosis of Lyme Borreliosis.

Diagn Microbiol Infect Dis. 2015 Nov;83(3):222-8. doi: 10.1016/j.diagmicrobio.2015.07.007. Epub 2015 Jul 17.

PMID:
26286381
18.

Humoral and cellular immune responses after influenza vaccination in patients with postcancer fatigue.

Prinsen H, van Laarhoven HW, Pots JM, Duiveman-de Boer T, Mulder SF, van Herpen CM, Jacobs JF, Leer JW, Bleijenberg G, Stelma FF, Torensma R, de Vries IJ.

Hum Vaccin Immunother. 2015;11(7):1634-40. doi: 10.1080/21645515.2015.1040207.

19.

Amyloid beta-42 (Aβ-42), neprilysin and cytokine levels. A pilot study in patients with HIV related cognitive impairments.

Mothapo KM, Stelma F, Janssen M, Kessels R, Miners S, Verbeek MM, Koopmans P, van der Ven A.

J Neuroimmunol. 2015 May 15;282:73-9. doi: 10.1016/j.jneuroim.2015.03.017. Epub 2015 Mar 21.

PMID:
25903731
20.

Natural Killer Cell Characteristics in Patients With Chronic Hepatitis B Virus (HBV) Infection Are Associated With HBV Surface Antigen Clearance After Combination Treatment With Pegylated Interferon Alfa-2a and Adefovir.

Stelma F, de Niet A, Tempelmans Plat-Sinnige MJ, Jansen L, Takkenberg RB, Reesink HW, Kootstra NA, van Leeuwen EM.

J Infect Dis. 2015 Oct 1;212(7):1042-51. doi: 10.1093/infdis/jiv180. Epub 2015 Mar 19.

PMID:
25791117
21.

Has CXCL13 an added value in diagnosis of neurosyphilis?

Mothapo KM, Verbeek MM, van der Velden LB, Ang CW, Koopmans PP, van der Ven A, Stelma F.

J Clin Microbiol. 2015 May;53(5):1693-6. doi: 10.1128/JCM.02917-14. Epub 2015 Mar 18.

22.

KIR and Human Leukocyte Antigen Genotype Associated Risk of Cytomegalovirus Disease in Renal Transplant Patients.

Michelo CM, van der Meer A, Tijssen HJ, Zomer R, Stelma F, Hilbrands LB, Joosten I.

Transplantation. 2015 Jul;99(7):1506-13. doi: 10.1097/TP.0000000000000497.

PMID:
25427165
23.

CD14/Toll-like receptors interact with bacteria and regulatory T-cells in the development of childhood asthma.

Klaassen EM, van de Kant KD, Soeteman M, Damoiseaux J, van Eys G, Stobberingh EE, Stelma FF, Quaak M, van Schayck OC, Jöbsis Q, Dompeling E.

Eur Respir J. 2014 Sep;44(3):799-802. doi: 10.1183/09031936.00020314. Epub 2014 Jul 17. No abstract available.

24.

HBsAg loss in patients treated with peginterferon alfa-2a and adefovir is associated with SLC16A9 gene variation and lower plasma carnitine levels.

Jansen L, de Niet A, Stelma F, van Iperen EP, van Dort KA, Plat-Sinnige MJ, Takkenberg RB, Chin DJ, Zwinderman AH, Lopatin U, Kootstra NA, Reesink HW.

J Hepatol. 2014 Oct;61(4):730-7. doi: 10.1016/j.jhep.2014.05.004. Epub 2014 May 10.

PMID:
24824278
25.

Non-syndromic hereditary sensorineural hearing loss: review of the genes involved.

Stelma F, Bhutta MF.

J Laryngol Otol. 2014 Jan;128(1):13-21. doi: 10.1017/S0022215113003265. Epub 2014 Jan 14. Review.

PMID:
24423691
26.

[Borrelial lymphocytoma].

Schatorjé EJ, van der Steeg H, Stelma F, Hebeda K, Warris A.

Ned Tijdschr Geneeskd. 2013;157(52):A6605. Dutch.

PMID:
24382037
27.

Circulating galectin-3 in infections and non-infectious inflammatory diseases.

ten Oever J, Giamarellos-Bourboulis EJ, van de Veerdonk FL, Stelma FF, Simon A, Janssen M, Johnson M, Pachot A, Kullberg BJ, Joosten LA, Netea MG.

Eur J Clin Microbiol Infect Dis. 2013 Dec;32(12):1605-10. doi: 10.1007/s10096-013-1919-4. Epub 2013 Jul 5.

PMID:
23828453
28.

Reduced PTLD-related mortality in patients experiencing EBV infection following allo-SCT after the introduction of a protocol incorporating pre-emptive rituximab.

van der Velden WJ, Mori T, Stevens WB, de Haan AF, Stelma FF, Blijlevens NM, Donnelly JP.

Bone Marrow Transplant. 2013 Nov;48(11):1465-71. doi: 10.1038/bmt.2013.84. Epub 2013 Jun 10.

PMID:
23749107
29.

Humoral and cellular immune responses after influenza vaccination in patients with chronic fatigue syndrome.

Prinsen H, de Vries IJ, Torensma R, Pots JM, Mulder SF, van Herpen CM, Elving LD, Bleijenberg G, Stelma FF, van Laarhoven HW.

BMC Immunol. 2012 Dec 17;13:71. doi: 10.1186/1471-2172-13-71.

30.

Absolute lymphocyte count predicts the response to new influenza virus H1N1 vaccination in pediatric cancer patients.

Mavinkurve-Groothuis AM, van der Flier M, Stelma F, van Leer-Buter C, Preijers FW, Hoogerbrugge PM.

Clin Vaccine Immunol. 2013 Jan;20(1):118-21. doi: 10.1128/CVI.00585-12. Epub 2012 Nov 21.

31.

Impact of bacterial colonization on exhaled inflammatory markers in wheezing preschool children.

van de Kant KD, Klaassen EM, van Aerde KJ, Damoiseaux J, Bruggeman CA, Stelma FF, Stobberingh EE, Muris JW, Jöbsis Q, van Schayck OC, Dompeling E.

J Breath Res. 2012 Dec;6(4):046001. doi: 10.1088/1752-7155/6/4/046001. Epub 2012 Sep 18. Erratum in: J Breath Res. 2012 Dec;6(4):049601.

PMID:
22990010
32.

The first locally acquired human infection of Echinococcus multilocularis in The Netherlands.

van Dommelen L, Stoot JH, Cappendijk VC, Abdul Hamid MA, Stelma FF, Kortbeek LM, van der Giessen J, Oude Lashof AM.

J Clin Microbiol. 2012 May;50(5):1818-20. doi: 10.1128/JCM.06355-11. Epub 2012 Feb 22.

33.

Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.

Meijer A, Jonges M, Abbink F, Ang W, van Beek J, Beersma M, Bloembergen P, Boucher C, Claas E, Donker G, van Gageldonk-Lafeber R, Isken L, de Jong A, Kroes A, Leenders S, van der Lubben M, Mascini E, Niesters B, Oosterheert JJ, Osterhaus A, Riesmeijer R, Riezebos-Brilman A, Schutten M, Sebens F, Stelma F, Swaan C, Timen A, van 't Veen A, van der Vries E, te Wierik M, Koopmans M.

Antiviral Res. 2011 Oct;92(1):81-9. doi: 10.1016/j.antiviral.2011.07.004. Epub 2011 Jul 13.

PMID:
21767571
34.

The contribution of water contact behavior to the high Schistosoma mansoni Infection rates observed in the Senegal River Basin.

Sow S, de Vlas SJ, Stelma F, Vereecken K, Gryseels B, Polman K.

BMC Infect Dis. 2011 Jul 18;11:198. doi: 10.1186/1471-2334-11-198.

35.

Toll-like receptors and microbial exposure: gene-gene and gene-environment interaction in the development of atopy.

Reijmerink NE, Kerkhof M, Bottema RW, Gerritsen J, Stelma FF, Thijs C, van Schayck CP, Smit HA, Brunekreef B, Postma DS, Koppelman GH.

Eur Respir J. 2011 Oct;38(4):833-40. doi: 10.1183/09031936.00099210. Epub 2011 Feb 24.

36.

Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus.

van der Vries E, Stelma FF, Boucher CA.

N Engl J Med. 2010 Sep 30;363(14):1381-2. doi: 10.1056/NEJMc1003749. No abstract available. Erratum in: N Engl J Med. 2011 Mar 24;364(12):1182. N Engl J Med. 2011 Jan 20;364(3):290.

37.

Could differential virological characteristics account for ongoing viral replication and insidious damage of the brain during HIV 1 infection of the central nervous system?

Vissers M, Stelma FF, Koopmans PP.

J Clin Virol. 2010 Dec;49(4):231-8. doi: 10.1016/j.jcv.2010.08.001. Epub 2010 Sep 15. Review.

PMID:
20833583
38.

Timing of infection and development of wheeze, eczema, and atopic sensitization during the first 2 yr of life: the KOALA Birth Cohort Study.

Mommers M, Thijs C, Stelma F, Penders J, Reimerink J, van Ree R, Koopmans M.

Pediatr Allergy Immunol. 2010 Sep;21(6):983-9. doi: 10.1111/j.1399-3038.2010.01042.x.

PMID:
20718929
39.

X-chromosome Forkhead Box P3 polymorphisms associate with atopy in girls in three Dutch birth cohorts.

Bottema RW, Kerkhof M, Reijmerink NE, Koppelman GH, Thijs C, Stelma FF, Smit HA, Brunekreef B, van Schayck CP, Postma DS.

Allergy. 2010 Jul;65(7):865-74. doi: 10.1111/j.1398-9995.2009.02291.x. Epub 2009 Dec 21.

PMID:
20028375
40.

TLR-related pathway analysis: novel gene-gene interactions in the development of asthma and atopy.

Reijmerink NE, Bottema RW, Kerkhof M, Gerritsen J, Stelma FF, Thijs C, van Schayck CP, Smit HA, Brunekreef B, Koppelman GH, Postma DS.

Allergy. 2010 Feb;65(2):199-207. doi: 10.1111/j.1398-9995.2009.02111.x. Epub 2009 Nov 25.

PMID:
19968634
41.

CD14 polymorphisms in mother and infant, soluble CD14 in breast milk and atopy development in the infant (KOALA Study).

Snijders BE, Stelma FF, Reijmerink NE, Thijs C, van der Steege G, Damoiseaux JG, van den Brandt PA, van Ree R, Postma DS, Koppelman GH.

Pediatr Allergy Immunol. 2010 May;21(3):541-9. doi: 10.1111/j.1399-3038.2009.00939.x. Epub 2009 Sep 15.

PMID:
19761511
42.

Interaction of T-cell and antigen presenting cell co-stimulatory genes in childhood IgE.

Bottema RW, Postma DS, Reijmerink NE, Thijs C, Stelma FF, Smit HA, van Schayck CP, Brunekreef B, Koppelman GH, Kerkhof M.

Eur Respir J. 2010 Jan;35(1):54-63. doi: 10.1183/09031936.00018909. Epub 2009 Jul 2.

43.

Early-life rotavirus and norovirus infections in relation to development of atopic manifestation in infants.

Reimerink J, Stelma F, Rockx B, Brouwer D, Stobberingh E, van Ree R, Dompeling E, Mommers M, Thijs C, Koopmans M.

Clin Exp Allergy. 2009 Feb;39(2):254-60. doi: 10.1111/j.1365-2222.2008.03128.x. Epub 2008 Nov 17.

PMID:
19032360
44.

Association of interacting genes in the toll-like receptor signaling pathway and the antibody response to pertussis vaccination.

Kimman TG, Banus S, Reijmerink N, Reimerink J, Stelma FF, Koppelman GH, Thijs C, Postma DS, Kerkhof M.

PLoS One. 2008;3(11):e3665. doi: 10.1371/journal.pone.0003665. Epub 2008 Nov 6.

45.

Occupational risk of human Cytomegalovirus and Parvovirus B19 infection in female day care personnel in the Netherlands; a study based on seroprevalence.

Stelma FF, Smismans A, Goossens VJ, Bruggeman CA, Hoebe CJ.

Eur J Clin Microbiol Infect Dis. 2009 Apr;28(4):393-7. doi: 10.1007/s10096-008-0635-y. Epub 2008 Oct 11.

PMID:
18850120
46.

Herpes simplex virus load in bronchoalveolar lavage fluid is related to poor outcome in critically ill patients.

Linssen CF, Jacobs JA, Stelma FF, van Mook WN, Terporten P, Vink C, Drent M, Bruggeman CA, Smismans A.

Intensive Care Med. 2008 Dec;34(12):2202-9. doi: 10.1007/s00134-008-1231-4. Epub 2008 Aug 5.

PMID:
18679655
47.

Interleukin 13, CD14, pet and tobacco smoke influence atopy in three Dutch cohorts: the allergenic study.

Bottema RW, Reijmerink NE, Kerkhof M, Koppelman GH, Stelma FF, Gerritsen J, Thijs C, Brunekreef B, van Schayck CP, Postma DS.

Eur Respir J. 2008 Sep;32(3):593-602. doi: 10.1183/09031936.00162407. Epub 2008 Apr 16.

48.

Breast-feeding duration and infant atopic manifestations, by maternal allergic status, in the first 2 years of life (KOALA study).

Snijders BE, Thijs C, Dagnelie PC, Stelma FF, Mommers M, Kummeling I, Penders J, van Ree R, van den Brandt PA.

J Pediatr. 2007 Oct;151(4):347-51, 351.e1-2. Epub 2007 Jul 12.

PMID:
17889066
49.

Consumption of organic foods and risk of atopic disease during the first 2 years of life in the Netherlands.

Kummeling I, Thijs C, Huber M, van de Vijver LP, Snijders BE, Penders J, Stelma F, van Ree R, van den Brandt PA, Dagnelie PC.

Br J Nutr. 2008 Mar;99(3):598-605. Epub 2007 Aug 29.

PMID:
17761012
50.

Toll-like receptor 4 polymorphism associated with the response to whole-cell pertussis vaccination in children from the KOALA study.

Banus S, Bottema RW, Siezen CL, Vandebriel RJ, Reimerink J, Mommers M, Koppelman GH, Hoebee B, Thijs C, Postma DS, Kimman TG, Stelma FF.

Clin Vaccine Immunol. 2007 Oct;14(10):1377-80. Epub 2007 Aug 15.

Supplemental Content

Loading ...
Support Center